July 23, 2026 · Form 4 insider transaction
ROTHBLATT MARTINE A bought 9,500 shares of United Therapeutics Corporation at $135.42 per share, a transaction worth $1.29M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.; Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.